Felix vs Maple: Which Gets You a GLP-1 Prescription?

The structural difference runs through every row, and it is a difference in what each company sells. Felix sells the medication as well as the assessment, so it publishes a price per pen for every product it dispenses. Maple sells access to clinicians, so it publishes membership and visit pricing and leaves the medication to the pharmacy that fills the prescription. Neither approach is better in the abstract — they answer different questions, and they fail differently: Felix’s cost is knowable before you apply but moves with your dose, while Maple’s platform cost is fixed and the medication cost is not knowable until a pharmacist quotes it. Maple does document a service line for this medication category by name, which this page previously said it could not confirm; that still commits no clinician to prescribing anything.

Start with geography, because it is binary. If you live in Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, or Prince Edward Island, Felix’s weight-management program is on your map (verified 2026-08-14) — and its shape favours a particular kind of reader: you have already decided you want to pursue this medication category, you want the medication priced by name and dose before you apply rather than quoted to you later, and you would rather start with a $0 visit than pay for one. What Felix asks in return is tolerance for a cost that moves: $40 on every follow-up, a per-pen medication price that escalates with dose, and figures published for Ontario after a Patient Support Program discount. The full process walkthrough — including what we have not been able to verify about it — lives in our Felix review.

Maple’s clearest case is the one this page used to miss: the parts of Canada Felix does not reach at all. Maple states its practitioners are available in every province and territory (verified 2026-08-14), which makes it a documented route for New Brunswick, Nova Scotia, and Newfoundland and Labrador residents, and for the territories — readers for whom the six-province programs are simply not an option. Two caveats belong with that, both from Maple’s own pages: its named Weight Medication Assessment specialty is available everywhere except Nova Scotia, Nunavut and the Northwest Territories, and outside Quebec Maple sells access as an $85-per-month membership rather than a one-off visit, with membership payments stated as non-refundable.

Quebec remains its own case, on its own Maple pricing page. Felix serves no line in Quebec and states it cannot even transfer a prescription to a Quebec pharmacy (verified 2026-08-14), while Maple prices Quebec at $95 per month or $210 for a single visit with a Quebec-licensed doctor, working — in Maple’s own words — with private doctors or nurse practitioners practising outside RAMQ. A Quebec resident who wants a clinician conversation online can have one through Maple; whether that conversation ends in any prescription is, as everywhere on this site, the clinician’s decision alone.

Maple also fits readers inside Felix’s six provinces who prefer a booked, visit-shaped interaction over an asynchronous application — or whose question is broader than one medication category, since a membership covers whatever they bring to it. The Quebec access picture as a whole, including public-plan coverage realities, lives at our Quebec page.

• Quebec: Felix’s program does not operate there and Felix cannot transfer a prescription to a Quebec pharmacy (verified 2026-08-14), so the Felix-vs-Maple question answers itself — Maple is the one on the map, at $95 per month or $210 per visit under its Quebec pricing. See our Quebec page.
• ON, MB, SK, AB, BC, PE: both models are plausible. Deciding factor one is money shape — a $0 first visit, $40 follow-ups and per-pen medication at Felix, versus an $85-per-month membership at Maple with medication billed by the pharmacy (verified 2026-08-14). Deciding factor two is interaction shape — application-and-review versus booked visit.
• NB, NL, and the territories: outside Felix’s weight-management program entirely (verified 2026-08-14), and this is where Maple stops being the alternative and starts being the answer — its practitioners are stated as available in every province and territory, with its Weight Medication Assessment specialty excluded only in Nunavut and the Northwest Territories among those. See the providers hub for the rest of the field, including Hims Canada, which lists coverage in all ten provinces and names no territory either way.
• Nova Scotia: the awkward one. Felix’s general practice lists Nova Scotia but its weight-management program does not, and Maple’s Weight Medication Assessment specialty excludes Nova Scotia specifically while its general practitioner access does not (verified 2026-08-14). Neither platform is a clean answer there; confirm with each directly before applying.
• Already prescribed elsewhere and looking to continue online: that is a renewal question more than a provider-comparison question — renewals covers how each model handles it.